WARREN, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that it will report results for the fourth quarter ended December 31, 2025 and provide an update on recent developments in its business after market close on Wednesday, March 4, 2026. Management will host a conference call ...

– Company entering 2026 with the potential to deliver multiple value-driving milestones, including data readouts from ARV-102, ARV-806, and ARV-393, with cash runway into second half of 2028 – – ARV-102 (LRRK2) Phase 1 clinical data in patients with Parkinson’s disease accepted for oral presentation at AP/PD Conference in March 2026 – – Clinical data from ARV-806 (KRAS G12D) and ARV-393 (BCL6) on track for presentations in 2026 – – Phase 1 trial in healthy volunteers initiated with polyQ-AR degrader ARV-02 ...

AMD and Meta Announce Expanded Strategic Partnership to Deploy 6 Gigawatts of AMD GPUs The 6-gigawatt agreement expands on the companies’ existing strategic partnership and aligns roadmaps across silicon, systems and software to deliver AI platforms purpose-built for Meta’s workloads. News Highlights Meta is partnering with AMD to rapidly scale AI infrastructure and accelerate the development and deployment of cutting-edge AI modelsAMD and Meta agree to a definitive multi-year, multi-generation partner ...

Results Demonstrate AT-587 To Be Highly Potent In Vitro Against Hepatitis E Virus Initiation of Phase 1 Clinical Program Anticipated Mid-2026 BOSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a late-stage clinical biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced in vitro results showing that two proprietary oral nucleotide analogs, AT-587 and AT-2490, exhibit pro ...

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Dryden Gold Corp. (TSX-V: DRY; FSE: X7W; OTCQX: DRYGF), a junior gold exploration company, has qualified to trade on the OTCQX® Best Market. Dryden Gold Corp. upgraded to OTCQX from the OTCQB® Venture Market. Dryden Gold Corp. begins trading today on OTCQX under the symbol “DRYGF.” U.S. investors can find current financial discl ...

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Nations Royalty Corp. (TSX-V: NRC; OTCQX: NRYCF), a royalty company focused on creating royalty diversification for First Nations and Indigenous groups, has qualified to trade on the OTCQX® Best Market. Nations Royalty Corp. upgraded to OTCQX from the OTCQB® Venture Market. Nations Royalty Corp. begins trading today on OTCQX und ...

AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor ACI-19764 is an orally available highly brain-penetrant small molecule NLRP3 inhibitorNLRP3 inhibitors are a major new class of compounds linked to a broad spectrum of inflammatory conditions including both metabolic and neurological diseasesACI-19764 is an important addition to AC Immune’s growing small molecule pipelinePhase 1 results in healthy volunteers are expected in H2 2026 Lausanne, Switzerland, February 24, 2026 -- AC Immune SA (NASDAQ ...

VANCOUVER, Canada, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTCQB: ORRCF) (the “Company” or “Oroco”) is pleased to announce that it has mobilized a diamond drill rig to its Santo Tomás copper project, located in northwestern Mexico, to commence drilling intended to support the upgrade of the mineral resource classifications in the project’s South Zone. This mobilization represents the practical start of Oroco’s Phase 2 on-site work program following the Company’s recent financing ...

Palo Alto, California, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB, MOBBW) (“Mobilicom” or the “Company”), a provider of cybersecurity and robust solutions for drones and robotics, today announced that it will attend Enforce Tac 2026, Germany’s prominent trade fair for security and defense, being held February 23–25, 2026, in Nuremberg, Germany. Mobilicom’s participation at Enforce Tac 2026 reflects the Company’s strategic commitment to expanding its footprint across the European Union— ...

NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced GR Silver Mining Ltd. (TSX-V: GRSL; OTCQX: GRSLF), a Canadian-based, Mexico-focused mineral exploration company, has qualified to trade on the OTCQX® Best Market. GR Silver Mining Ltd. upgraded to OTCQX from the OTCQB® Venture Market. GR Silver Mining Ltd. begins trading today on OTCQX under the symbol “GRSLF.” U.S. investors ca ...